SCHEMBL2239332

SCHEMBL2239332

CCOC[SiH](COCC)COCC

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5186435 0.74
Ether SCHEMBL21406 0.69 ALDH1A1 (0.47) ALDH1A1
Ether SCHEMBL6 0.69
Ether SCHEMBL8160191 0.69 ALDH1A1 (0.47) ALDH1A1
Ether SCHEMBL9248046 0.69 ALDH1A1 (0.47) ALDH1A1
Ether SCHEMBL9248674 0.69 ALDH1A1 (0.47) ALDH1A1
Ether SCHEMBL5695366 0.67
Ether SCHEMBL11883416 0.65
Ether SCHEMBL8322124 0.65 ALDH1A1 (0.44) ALDH1A1
Ether SCHEMBL9448930 0.65 ALDH1A1 (0.44) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141188-B1 SILICON-CONTAINING COMPOUND, CURABLE COMPOSITION AND CURED PRODUCT ADEKA CORP (JP) 2014-04-23 EP disclosed
US-8003736-B2 Silicon-containing compound, curable composition and cured product ADEKA CORPORATION (JP) 2011-08-23 US disclosed
US-20100179283-A1 SILICON-CONTAINING COMPOUND, CURABLE COMPOSITION AND CURED PRODUCT ADEKA CORPORATION (JP) 2010-07-15 US disclosed
EP-2141188-A1 SILICON-CONTAINING COMPOUND, CURABLE COMPOSITION AND CURED PRODUCT Adeka Corporation (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179283-A1 SILICON-CONTAINING COMPOUND, CURABLE COMPOSITION AND CURED PRODUCT H1-0, H1-10, H1-2 ALDH1A1 1328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.